Telix selects IBA Cyclone KIUBE for US manufacturing expansion

Telix Pharmaceuticals has selected IBA Cyclone KIUBE cyclotrons to support its manufacturing expansion in the US. The four initial cyclotrons will be installed at RLS Radiopharmacies sites to produce isotopes and radiopharmaceuticals for cancer care. The agreement supports Telix's strategic expansion and strengthens IBA's position in the market. The Cyclone KIUBE 180 cyclotrons will be equipped with QUANTM Irradiation System (QIS) for cGMP-compliant production of critical radio-metals.